Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • OmniActive Health...

    OmniActive Health acquires 85 percent stake in Indfrag

    Written by supriya Published On 2017-01-11T11:06:28+05:30  |  Updated On 11 Jan 2017 11:06 AM IST
    OmniActive Health acquires 85 percent stake in Indfrag

    New Delhi : OmniActive Health Technologies, which supplies ingredients to the healthcare and food industries, has acquired 85 per cent stake in Bengaluru-based fragrance and specialty chemicals maker Indfrag for an undisclosed amount.


    The Mumbai-based firm has also entered into definitive agreements with Indfrag to acquire the balance stake in couple of months.


    "The acquisition provides us distribution capability in markets like South Korea and US. The buyout would also help us gain access to extracts which are used in production of nutraceutical products," OmniActive Health Technologies Managing Director and CEO Sanjaya Mariwala told .


    The buyout also provides the company with additional production capacity as well as bolster its overall product portfolio, he added.


    "Indfrag is very strong in markets like Korea where they have optimum distribution set up. We expect to add around 30-35 per cent in our top line due to this buyout," Mariwala said.


    The acquisition includes all products related to Indfrag's food and nutrition business. OmniActive has acquired Indfrag by raising funds from various sources including the recent PE investment by Ever stone.


    Industry sources pegged the deal size at around USD 80 million.


    Indfrag has a significant presence in the international market as a leading supplier of high quality botanical and plant extracts from India and South East Asia for the dietary supplement and nutraceuticals industry.


    It has a leading position in Garcinia Cambogia, Green Coffee, Valerian and natural Caffeine extracts. Besides, the company is a prime manufacturer of other products such as turmeric, green tea boswellia and fenugreek.


    "By coming together, both companies intend to spearhead industry efforts to bring to our customers fully authenticated and validated extracts that meet the emerging standards of safety, reliability, transparency and traceability," Mariwala said.


    Indfrag will operate as an independent business, and OmniActive and Indfrag teams will continue to manage their respective product lines and customers.


    Besides Mariwala, Deep Mishra, Managing Director at Everstone India and Chaitanya Desai, Chief Operating Officer at OmniActive, will be joining the Board of Indfrag.


    Philip Samuel, Indfrag's founder will continue as Chairman of the board.

    agreementChaitanya DesaiDeep MishraIndfragnutraceuticals industryOmniActive HealthSanjaya Mariwala
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya
    supriya
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok